drugset / Trial / NCT04987229
Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the long-term safety and tolerability of OLZ/SAM in pediatric subjects with schizophrenia or Bipolar I disorder
Timeline
- Start
- 2021-10-22
- Primary completion
- 2027-09
- Completion
- 2027-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | — | — |
| Subject | Samidorphan | Small molecule | — | — |